Lumida
/BOW
⌘K
Bowhead Specialty Holdings Inc

Bowhead Specialty Holdings Inc

BOW
$30.70USD↑+0.85%+0.26 today

MARKET CAP

1.0B

P/E (TTM)

17.0x

FWD P/E

14.0x

DAY RANGE

$30 – $32

52W RANGE

$21
$34

AI Summary

Stalk
StalkMedium

BOW remains in a Stage 2 advancing uptrend with rising EMAs underpinning higher highs and higher lows, but overbought RSI readings and exhaustion candles at recent highs warn of near-term fatigue. We defer buying and stalk for a pullback into the rising 9/21 EMA support zone as the optimal entry region.

  • ↑Q1 GWP rose 24% YoY to $217M; adjusted net income up 40% to $16M (EPS $0.48).
  • ↑Expense ratio declined to 28.4% and combined ratio held at ~95.3%, showing disciplined underwriting.
  • ↓Intensifying specialty insurance competition may erode pricing discipline in casualty lines.
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

Bowhead Specialty Holdings Inc. (NASDAQ: BOW) operates in the specialty insurance industry, focusing on sectors such as casualty, professional liability, and healthcare liability. The company has positioned itself as a leader in leveraging both traditional craft underwriting methods and innovative digital underwriting platforms to capture market growth, particularly among small to mid-sized enterprises (SMEs). Bowhead seeks to capitalize on market demand driven by an increasing need for specialized insurance solutions amidst a competitive landscape.

Bull says

  • ↑Q1 GWP rose 24% YoY to $217M; adjusted net income up 40% to $16M (EPS $0.48).
  • ↑Expense ratio declined to 28.4% and combined ratio held at ~95.3%, showing disciplined underwriting.
  • ↑Baleen digital platform generated $11M in Q1 premiums with 75% quote conversion rate.
  • ↑Consensus Moderate Buy with $33.14 average 12-month price target supports valuation upside.
  • ↑Equity base of $459M yields $13.80 book value per share; low leverage enhances stability.
  • ↑Strong earnings yield and low volatility suggest resilient performance in market swings.

Bear says

  • ↓Intensifying specialty insurance competition may erode pricing discipline in casualty lines.
  • ↓Social inflation driving claims costs higher, risking reserve adequacy and margins.
  • ↓Healthcare liability regulatory changes create compliance uncertainty and limit market opportunities.
  • ↓Large tech investments risk margin dilution if operational efficiencies lag expectations.
  • ↓Elevated short interest and negative dividend yield signal shareholder skepticism on returns.
  • ↓Size and liquidity weaknesses may expose the stock to volatility in downturns.

Investment themes with BOW

L&H Insurance↑ +0.32%

PGR · TRV · ALL

Earnings Call · Q1 2026 · Mgmt. Guidance

Updated 05-17-2026neutral

Transcript signals

Bull points

  • Both have generated adjusted net income of $16 million in the first quarter of 2026, up approximately 40% year over year.
  • Gross written premiums increased 24% to approximately $217 million for the quarter.
  • Our expense ratio for the quarter was 28.4%, a decrease of two points compared to 30.4% year-over-year, primarily driven by a 2.9-point decrease in our operating expense ratio.

Bear points

  • The increase in our net acquisition ratio was driven by the increase in broker commissions due to mixed changes in our portfolio, especially as more premiums are sourced from wholesalers and the feeding fee we pay to American families.
  • Yeah, the headline on that is basically neutral to net income. There will be some puts and take. Obviously, as we see more premium, net earned premium will go down. But obviously, our losses will go down and our senior commission should come up. There will also be maybe a little bit of pressure on investment income as we pay more to our reinsurers up front.
  • Partially offsetting this growth was a reduction in our commercial public D&O portfolio, driven by lost renewals to markets who we believe have over-aggressive appetites and little to no discipline.
Read full transcript analysis ›